Affordable Access

Publisher Website

Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid

Authors
Journal
Clinica Chimica Acta
0009-8981
Publisher
Elsevier
Publication Date
Volume
196
Identifiers
DOI: 10.1016/0009-8981(91)90070-s
Keywords
  • Enzyme-Linked Immunosorbent Assay
  • Apolipoprotein E
  • Apolipoprotein B
  • Cerebrospinal Fluid
  • Neurological Diseases
Disciplines
  • Biology
  • Medicine

Abstract

Abstract Apolipoprotein E was measured in paired sera and cerebrospinal fluid samples from 483 neurological patients. The average apolipoprotein E concentration was 7.5 (±3.1) mg/l in cerebrospinal fluid and 93.5 (±29.7) mg/l in serum. Mean apolipoprotein B concentrations in 88 patients were 0.77 ± 3.4 mg/l in cerebrospinal fluid and 1.06 ± 0.31 g/l in serum. The apolipoprotein E concentration in cerebrospinal fluid was much greater than expected for passive diffusion from serum. By contrast to apolipoprotein B, there was no correlation between the apolipoprotein E cerebrospinal fluid/serum concentration quotient and the albumin concentration quotient. This suggests that apolipoprotein E in cerebrospinal fluid, unlike apolipoprotein B, is locally synthesized and that the use of a cerebrospinal fluid/serum concentration quotient is unnecessary. In a control group ( n = 64) the mean cerebrospinal fluid apolipoprotein E value (± SD) was 5.9 (1.6) mg/l. Elevated cerebrospinal fluid apolipoprotein E concentrations were observed in acute ( n = 22, 12.5 ± 6:2 mg/l) and chronic inflammatory central nervous system diseases ( n = 15, 10.4 ± 2.4 mg/l).

There are no comments yet on this publication. Be the first to share your thoughts.